Author Guidelines
Updated March 2021
Acta Obstetricia et Gynecologica Scandinavica (AOGS) is an international journal of obstetrics and gynecology and publishes articles on all aspects of women´s health. Priority is given to articles containing original and innovative research data that have clinical relevance. The journal is owned by the Nordic Federation of Societies of Obstetrics and Gynecology (NFOG) and published by Wiley.
Manuscript Submission
Submission to the journal is made through http://mc.manuscriptcentral.com/aogs. For additional assistance, contact the Editorial Office at: acta.obstet.gynecol@obgyn.gu.se.
As part of the journal’s commitment to supporting authors at every step of the publishing process, AOGS requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Please see Wiley’s resources on ORCID here. Also, in accordance with the International Committee of Medical Journal Editors (ICMJE) recommendations, we encourage all contributing authors to link their name with Open Researcher and Contributor Identification.
Please prepare your manuscript giving careful attention to the journal's language, style and format. Perform a professional linguistic revision before submission and write a cover letter. Follow the specific guidelines for the type of manuscript you plan to submit: original research article, systematic review, state-of-the-art review, commentary, and letter to the Editor.
AOGS does not publish case reports, research protocols and, as a general rule, validations of existing questionnaires in another language or the results of such validation studies. Editorials and book reviews are by invitation only.
AOGS encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.
AOGS will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
Authors must confirm that the manuscript is submitted solely to AOGS, and is not under consideration by any other journal and has not been published previously in another journal (including publication in another language).
Our helpful guide will make your paper more discoverable with Search Engine Optimization.
Editorial Decision
Evaluation of the manuscript includes a combined editorial and external peer-review process. Decisions are made based on the quality of submitted manuscripts including novelty of the idea/hypothesis, reliability of data, appropriateness of interpretation of findings, validity of results and conclusions. Ethical aspects, language and presentation, clinical implications, relevance to the journal´s readership and overall priority will also be taken into account during the decision making process.
Publication and Copyright
After acceptance for publication, the authors can chose between copyright transfer and open access. Please read the specific information on the possibilities and conditions as well as the timeline of the publication process.
Publication Ethics
AOGS is a member of the Committee on Publication Ethics (COPE) and please note that by submitting your manuscript to AOGS you accept that your manuscript may be screened for plagiarism against previously published articles.
cope ithenticate
Manuscript Language, Style and Format
Language
Authors for whom English is a second language may choose to have their manuscript professionally edited before submission. The English Language Editing Service can help to ensure your paper is clearly written in standard, scientific English language appropriate to your discipline. Visit Wiley English Language Editing Service to learn about the different options. All services are paid for and arranged by the author, and use of one of these services does not guarantee acceptance or preference for publication.
Manuscripts should be written in clear and concise scientific English, and American spelling should be used throughout (see below). It is the responsibility of authors to ensure the quality of the language in submitted manuscripts. Note that command of colloquial English is not sufficient and this is not the same as scientific medical English for which professional services may be needed.
Article Preparation Support
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence. Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
Style and Format
The text of your article must be prepared using a word processing program and saved as a .doc, .rtf, or .ps file (no pdf files please). The text should use 1.5 spacing with generous margins. Times New Roman in 12 pt size is the preferred font style. Smaller spacing and font may be used for the reference list, and within tables and figures.
Note that “e” and “o” is used instead of “ae” or “oe” (gynecology instead of gynaecology, cesarean instead of caesarean, anemia instead of anaemia, hematology instead of haematology, hemorrhage instead of haemorrhage, fetus instead of foetus, and estrogen instead of oestrogen).
Numbers one to nine that are free-standing in the text should be spelt out; for 10 or more people, objects, days, months etc. use Arabic numerals.
“Women” is generally preferred to “patients” where possible and where disease is not the issue in question. The use of the term "subjects" is discouraged as a less than ideal reference to women. “Relation to, with, between” is preferred to “relationship”, which should be reserved for what is interpersonal. Birthweight should be one word, as is "percent". Use appropriate symbols such as ≤, ≥, ±, ®,™ where indicated. Write "eg" instead of "e.g." and "vs" instead of "versus".
Cover letter
In a cover letter authors should introduce the material sent to the journal, and comment on its appropriateness for the journal or other reasons that prompted submission to AOGS. Indicate, if appropriate, that you have followed the specific EQUATOR reporting guidelines for your type of study.
For clinical trials involving intervention, authors must provide the trial registration number and the name of the publicly accessible registry (such as http://www.clinicaltrials.gov; http://isrctn.org, or one of the WHO Primary Registries that meet the ICMJE requirements: http://www.who.int/ictrp/network/primary/en/) in which the trial has been registered. For clinical trials commenced after 1 July 2008 the registration must have been prospectively done.
Authors should also inform the Editors of any special circumstances or details regarding the submitted material, including prior submission/publication of the material or parts of the material to another journal or another language.
In case the manuscript has been reviewed elsewhere before this submission, please include the reviews and your responses to prior criticism as an additional file. Although our peer review will proceed independently of previous evaluation, it may help to expedite the decision process. Preferred and non-preferred reviewers may be mentioned.
A paragraph in the Cover Letter explaining each author's contribution is required.
⇒ See format summary here
Original Research Article
Manuscript structure
Title page, Conflicts of Interest statement, Funding information, Abstract, Keywords, Abbreviations, Key Message, Main text, including; Introduction, Material and methods, Results, Discussion and Conclusion, Acknowledgments, Author contribution statement, References, Legends of supporting information (if any), Legends of Tables and Figures, and Tables and/or Figures.
• Title page – should include: a) full title of the article (title should be descriptive, clear, concise and incorporate keywords/phrases without using abbreviations or proprietary names) b) all contributing authors with full name (first name, middle name(s) if appropriate, and surname followed by degrees c) affiliation(s) (institution, town and country) in English. Affiliations are marked with superscript numbers and d) corresponding author (only one) details to whom all decision letters and page proofs will be communicated (give the professional address and include telephone with country code and e-mail).
• Conflict of Interest statement - all authors must state explicitly whether potential conflicts of interest do or do not exist on a separate page following the title page. Authors are responsible for disclosing all financial and personal relationships that could be viewed as presenting a potential conflict of interest (such as patent or stock ownership, consultancies, speaker's fees, personal, political, intellectual or religious interests). For more information on what constitutes a Conflict of Interest, please see the ICMJE information page.
• Funding information – Financial and material support must be acknowledged. Grant bodies and major financial contributors should be listed. If no specific funding was obtained, this should also be stated.
• Abstract – a structured abstract of no more than 350 words is required, subdivided into the following sequential sections: Introduction, Material and methods, Results, and Conclusions. Clinical trials registration information (Unique Identifier and URL) must be included in the Abstract.
• Keywords - include 5-8 keywords for indexing services and other search facilities for published material. Standardized medical subject headings (MeSH terms) are preferred.
• Abbreviations - Provide a list of abbreviations used in the main text five or more times (excluding the Abstract). Use only widely accepted and conventional abbreviations. If an abbreviation appears four times or less in the manuscript it should not be used. Avoid abbreviations in the Abstract.
• Key Message - Provide a key message from the article, which will be published in a box at the front of the article, of maximum of 40 words. This should contain one to three short sentences phrased differently from the conclusion. Emphasize the main problem targeted and to what degree it was solved or new knowledge was added.
• Main text - The text should be 1000-3000 words and structured with the following headings (bold, upper case): Introduction (including background, hypothesis, aims and objectives), Material and methods (including information on study design, research methods, statistical analysis, ethical approval and consent), Results, Discussion (including interpretation of main findings, validity of results, strengths and limitations of the study) and Conclusion. Subheadings should be limited except when describing complicated methodology.
1. Introduction
Provide a relevant background and introduce the problem being investigated citing key published work. Clearly state the purpose or objective of the research and what questions are to be addressed or answered – preferably in one page or less.
2. Material and methods
The design of investigations, methods of analysis, source of data and outcome measures should be described in sufficient detail to permit the study to be repeated by others and must include specification of all statistical methods. See also EQUATOR website for reporting guidelines: www.Equator-network.org.
Generic names of drugs should be used unless a proprietary name is directly relevant. Any specialized equipment, chemical or pharmaceutical product cited in the text must be accompanied by the manufacturer's name or web-address.
When reporting cohort studies please use the term reference group, and use the term controls /control group only for case-control studies. When reporting results of a historical cohort study, please use the term historical cohort rather than retrospective cohort.
Decimals should be indicated by points (not commas) after the whole number (for example 0.5; 0.001) and thousands by an extra space for figures over 9999, but not by commas or points (for example 1000, 20 500).
Present methods of statistical analyses and, when appropriate, power calculations in a separate subsection called Statistical Analyses. State what statistical methods were used for different parts of the study and give details of test values as appropriate. Cite statistical software programs used. Measurements should be expressed in SI units with the exception of blood pressure (mmHg). See also the IUB Biochemical Nomenclature on http://www.sbcs.qmul.ac.uk/iupac/jcbn/ for further information.
At the end of the Material and methods section, under a subheading called Ethical approval, authors must include specific information on ethical committee/institutional review board approval (e.g. name of the ethical committee, reference number and date of approval) and - if applicable - data protection authority permission. For clinical trials, authors must provide the registration date, the trial registration number, the name of the publicly accessible registry where it is registered, the URL address of the trial registry, and the date of initial participant enrollment.
3. Results
Present the findings in appropriate detail. Duplication between text and tables or figures should be avoided. Related subject matters should be joined in paragraphs (avoid one sentence paragraphs).
Express probability values to no more than three decimals (P, uppercase in italics). Please provide actual P-values and avoid the use of NS (not significant). Confidence intervals (CI) should be reported with a maximum of two digits and “-“between values unless they are negative in which case “to” between values should be used (such as CI 1.84 - 3.26; CI -2.35 to -4.56), and in tables they should be in a separate marked column. In tables use the % mark above a column or percentage values and avoid internal brackets/parentheses in the tables. For mathematical equations use italic type for variables and single letters and write them on a single line if possible.
4. Discussion
Raise implications of the findings reported and compare them with those of earlier reports. The focus of this section should be the importance of the actual main findings to clinicians and patient care. It may be helpful in developing arguments to reiterate some of the findings, but avoid repetition of results given earlier in the article. A complete review of the literature is not necessary, nor to restate in detail findings from other studies. Strengths and limitations of the study should be discussed. No subheadings allowed.
5. Conclusion
Provide a final concise summary of your findings in one short paragraph at the end of discussion considering implications for clinical practice and future research. Although some degree of speculation is permissible, avoid unfounded conclusions.
• Acknowledgments - Persons who have made a valuable contribution but do not meet the criteria for authorship should be listed in an acknowledgments section at the end of the manuscript.
• Author contributions – Please state how each author has contributed to the submitted study,
• Tweetable Abstract - Please provide the "bottom line" in no more than 22 words. Please add the Twitter handles (eg. @aogs_tweets) of the authors if available.
……
更多详情：
https://obgyn.onlinelibrary.wiley.com/hub/journal/16000412/about/author-guidelines
